QuartzOzempic hits booze sales, Moderna likes AI, Biogen's blockbuster drug9 hours agoBruce GilBy Bruce Gilmore_vert
FiercePharmaTakeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB6 hours agoZoey BeckerBy Zoey Beckermore_vert
Business InsiderPharma giant plans to cash in on 'Ozempic face' craze with fillersYesterdayGeoff Weiss & Julia PugachevskyBy Geoff Weiss & Julia Pugachevskymore_vert
New York Post Face filler expected to soar with cases of gaunt 'Ozempic face' — and one company is cashing in3 hours agoBrooke KatoBy Brooke Katomore_vert
BloombergWe Can Fix Your 'Ozempic Face,' Skincare Firm Galderma Says2 days agoAllegra CatelliBy Allegra Catellimore_vert
POLITICOXavier Becerra plots political future after Biden administration3 days agoDaniel LippmanBy Daniel Lippmanmore_vert
New York Post Xavier Becerra weighs run for California governor as unpopular official explores leaving Biden admin3 days agoJosh ChristensonBy Josh Christensonmore_vert
iHeartANALYST: Could Xavier Bacerra Be Making A California Gubernatorial Run?20 hours agoJensen RaderBy Jensen Radermore_vert
Daily CallerTop Biden Cabinet Pick Xavier Becerra Reportedly Plotting His Exit3 days agoReagan ReeseBy Reagan Reesemore_vert
FiercePharmaBristol Myers Squibb leans on long-term growth drivers, strategy overhaul to dodge IRA impactsYesterdayZoey BeckerBy Zoey Beckermore_vert
Fierce BiotechBMS closes Redwood City cell therapy research site3 hours agoMax BayerBy Max Bayermore_vert
CNBCBristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossYesterdayAnnika Kim ConstantinoBy Annika Kim Constantinomore_vert
BioSpaceBMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1YesterdayTristan ManalacBy Tristan Manalacmore_vert
Barron'sBristol Myers Cuts Full-Year Earnings Forecast, Launches Cost CutsYesterdayAngela PalumboBy Angela Palumbomore_vert
STATPBMs and pharma spend big on lobbying Congress - STAT3 days agoRachel CohrsBy Rachel Cohrsmore_vert
Accountable.USNew Reports Show Massive Big Pharma Influence-Peddling to Stop President Biden’s Medicare Drug Price Negotiation4 days agomore_vert
CGTNChina looks to inject new energy into pharmaceutical sectorYesterdayJulia LyubovaBy Julia Lyubovamore_vert
FiercePharmaNovartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO3 days agoFraiser KansteinerBy Fraiser Kansteinermore_vert
FiercePharmaNovartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia8 hours agoAngus LiuBy Angus Liumore_vert
Financial TimesBristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharmaYesterdayOliver BarnesBy Oliver Barnesmore_vert
LA Daily NewsXavier Becerra champions Biden Administration’s efforts to uplift caregiversYesterdayClara HarterBy Clara Hartermore_vert
Next AvenueA Year of Progress: Recognizing America's Family Caregivers7 hours agoJason Resendez & Terry T. FulmerBy Jason Resendez & Terry T. Fulmermore_vert
AARP BlogsAnniversary of Sweeping Executive Order Marks 'Pivotal' Moment for Caregivers8 days agoNatalie MissakianBy Natalie Missakianmore_vert
MSNXavier Becerra champions Biden Administration's efforts to uplift caregivers2 days agoClara HarterBy Clara Hartermore_vert
Yahoo FinancePharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates2 hours agoKinjel ShahBy Kinjel Shahmore_vert
ReutersAstraZeneca leaps after smashing first-quarter forecastsYesterdayEva Mathews & Maggie FickBy Eva Mathews & Maggie Fickmore_vert
BloombergAstraZeneca's Profit Gains on Sales of Cancer DrugsYesterdayAshleigh FurlongBy Ashleigh Furlongmore_vert
Investor's Business DailyAstraZeneca Stock Flirts With Breakout As Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge22 hours agoAllison GatlinBy Allison Gatlinmore_vert
TipRanksAZN Earnings: AstraZeneca Soars on Impressive Q1 Results - TipRanks.comYesterdayKailas SalunkheBy Kailas Salunkhemore_vert
Racine County EyeEli Lilly’s acquisition of Nexus facility marks a new era for Pleasant Prairie’s pharmaceutical landscape1 hour agoDenise LockwoodBy Denise Lockwoodmore_vert
Investors | Eli Lilly and CompanyLilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals | Eli Lilly and Company4 days agomore_vert
ReutersEli Lilly to acquire manufacturing facility from Nexus Pharma4 days agoChristy Santhosh & Muhammad Tasim ZahidBy Christy Santhosh & Muhammad Tasim Zahidmore_vert
Yahoo FinanceLilly to buy injectable drug plant in manufacturing ramp-up4 days agoDelilah AlvaradoBy Delilah Alvaradomore_vert
TipRanksEli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans - TipRanks.com4 days agoSteve AndersonBy Steve Andersonmore_vert
ReutersGilead posts quarterly loss on acquisition charge, revenue rises 5%21 hours agoDeena BeasleyBy Deena Beasleymore_vert
GlobeNewswireDrug Delivery Technologies market is projected to grow at a CAGR of 5.5% by 2034: Visiongain5 hours agomore_vertFull Coverage of this story
OutSourcing-Pharma.comElevating pharmaceutical solutions: An interview with LGM Pharma7 hours agoLiza LawsBy Liza Lawsmore_vert
The Medicine MakerCrowdsourcing Project to Tackle Drug-Resistant Epilepsy7 hours agoRob CokerBy Rob Cokermore_vert
Little Black Book - LBBonlineGerety Talks Health and Pharma Advertising | LBBOnline6 hours agomore_vert
Pharmaceutical ExecutivePharma Pulse 4/26/24: 20 States Select Direct Care Workforce Enhancement Programs by HHS, Do Assigned Roles in Clinical Trials Affect Patient-Reported Outcomes? & more8 hours agoMiranda SchmalfuhsBy Miranda Schmalfuhsmore_vert
Crain's New York BusinessRegeneron inks $100M deal to develop gene-editing therapies8 hours agoJacqueline NeberBy Jacqueline Nebermore_vert
Fierce BiotechRegeneron signs Mammoth gene editing deal worth $100M upfrontYesterdayAnnalee ArmstrongBy Annalee Armstrongmore_vert
The Business JournalsPeninsula biotech co-founded by Jennifer Doudna lands CRISPR gene-editing pact with Regeneron - San Francisco Business TimesYesterdayRon LeutyBy Ron Leutymore_vert
AOLRegeneron to collaborate on gene editing therapies with Doudna-founded MammothYesterdayChristy SanthoshBy Christy Santhoshmore_vert
Pink SheetDanes Advise Pharma Firms To Test Their Anti-Tamper Devices9 hours agoIan SchofieldBy Ian Schofieldmore_vert
Simply Wall StUnpleasant Surprises Could Be In Store For Royalty Pharma plc's (NASDAQ:RPRX) SharesYesterdaymore_vert
London Loves BusinessAnalyst sees over 100% upside potential in this pharma stockYesterdayThea CoatesBy Thea Coatesmore_vert
AccessWirePharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency4 hours agomore_vert
Life Science Leader MagazineReviva Pharma's Novel Funding Approach In Schizophrenia19 hours agoBen ComerBy Ben Comermore_vert
Proactive Investors USARecce Pharmaceuticals R327 approved for increase to 4000mg IV over a fast infusion of 30 minutes16 hours agomore_vert
Simply Wall StCSPC Innovation Pharmaceutical First Quarter 2024 Earnings: EPS: CN¥0.056 (vs CN¥0.095 in 1Q 2023)16 hours agomore_vert
MedicalResearch.comBypassing Safeguards: The Issue of Substandard Drugs in the US and EU22 hours agomore_vert
Pharmacy Practice NewsIllegal Web Pharmacies and Social Media Drug Sales Target Teens4 days agomore_vert
BloombergScholz Gets Another Pharma Boost With New Merck KGaA SiteYesterdaySonja Wind & Tim LohBy Sonja Wind & Tim Lohmore_vert
Merck KGaAMerck Invests More Than € 300 Million in New Life Science Research Center in Germany | MerckYesterdaymore_vert
BioProcess InsiderGermany's Merck breaks ground on $321m biomanufacturing centerYesterdayShreeyashi OjhaBy Shreeyashi Ojhamore_vert
Pharmaceutical TechnologyMerck plans €300m investment at new German research centreYesterdaymore_vert
PR NewswireDeloitte's 14th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rebounds After Record LowYesterdaymore_vert
Concerned Women for AmericaSecretary of Health Reveals Radical HHS Abortion Policy | CONCERNED WOMEN FOR AMERICA6 hours agoMaggie MckneelyBy Maggie Mckneelymore_vert
KVOA Tucson NewsThe Secretary of Health and Human Services took trip to Phoenix to talk action3 days agomore_vert
PR NewswirePerrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionYesterdaymore_vert
Investors in HealthcareFrance: Esteve Healthcare acquires Perrigo's HRA Pharma Rare Diseases business7 hours agoNick HerbertBy Nick Herbertmore_vert
Grand Rapids Business JournalPerrigo to sell HRA Pharma Rare Diseases unit in $294M dealYesterdayMark SanchezBy Mark Sanchezmore_vert
Investing.com South AfricaPerrigo agrees to sell rare disease unit to Esteve for €275 million22 hours agomore_vert
Life Sciences Intellectual Property ReviewGSK settles HIV drug licensing dispute | Big PharmaYesterdaymore_vert
GlobeNewswireInhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center StageYesterdaymore_vert
Seeking AlphaTakeda leaves industry trade group BIO (NYSE:TAK)22 hours agoDulan LokuwithanaBy Dulan Lokuwithanamore_vert
Yahoo FinanceSanofi profit slips on generic competition and currency effectsYesterdayLudwig BurgerBy Ludwig Burgermore_vert
BloombergSanofi Posts Strong Sales Growth With New Hemophilia MedicineYesterdayTim LohBy Tim Lohmore_vert
The Hastings TribuneFSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM)Yesterdaymore_vertFull Coverage of this story
Pharmaceutical TechnologySocial prescribing: friend or foe for pharma?2 days agoJenna PhilpottBy Jenna Philpottmore_vert
Business WireIncyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists3 days agomore_vert
Fierce BiotechIncyte, fresh off gaining MorphoSys drug, buys Escient for $750M3 days agoMax BayerBy Max Bayermore_vert
Law360Fenwick, Covington Build $750M Sale Of Pharmaceutical Biz3 days agoJade Martinez-pogueBy Jade Martinez-poguemore_vert
ZAWYAHikma has strong start to 2024, with continued momentum across all businessesYesterdaymore_vertFull Coverage of this story
MaerskNavigating New Trends in Pharmaceutical Supply Chains: Strategies for Success15 days agomore_vert
BioSpacePharmaceutical CDMO Industry is Rising Rapidly Up to USD 295.95 Bn by 20337 days agomore_vert
PharmiWeb.comBiopharmaceutical CMO and CRO Market Estimated to Reach USD 60.3 Billion by 2033 | Market.us9 days agomore_vert
WhaTechBiotechnology Contract Manufacturing Market Anticipated to reach $24.8 As Revealed In New Report billion by...3 days agomore_vert
BioSpaceU.S. Biopharmaceutical CMO & CRO Market Size, Share & Growth Report, 203311 days agomore_vert
WhaTechContract Pharmaceutical Manufacturing Market Business Growth, Development Factors, Current and Future Trend...7 days agomore_vert
FiercePharmaTop 20 pharma companies by 2023 revenue11 days agoKevin DunleavyBy Kevin Dunleavymore_vert
NotiméricaZentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply22 hours agomore_vert
European Medicines Agency |New recommendations to strengthen supply chains of critical medicines | European Medicines Agency3 days agomore_vert
Regulatory FocusEU group calls for multi-prong measures to tackle shortages3 days agoJoanne EglovitchBy Joanne Eglovitchmore_vert
The Pharmaceutical JournalEMA may ask manufacturers to increase production capacity in response to medicines shortagesYesterdayDavid LipanovicBy David Lipanovicmore_vert
EURACTIVCritical Medicines Alliance is 'wake-up call', says French minister of industry3 hours agoClara BauerBy Clara Bauermore_vert
Senator Sherrod BrownSenator Brown: Continuing the Fight Against Big Pharma to Lower Insulin Costs | Senator18 days agomore_vert
The Siasat DailyVideo: Massive fire at Telangana pharma company, several workers trapped5 hours agomore_vert
NewsTapA boy demonstrates spontaneity, rescues workers trapped in Alvin Pharma fire mishap2 hours agoA Saye SekharBy A Saye Sekharmore_vert
NairametricsEmzor Pharmaceuticals to construct $23 Million API facility in Ogun State to combat malaria7 hours agoChioma ChukwuneduBy Chioma Chukwunedumore_vert
Zee Business8 large- and mid-cap pharma stocks that have more than doubled in a year9 hours agomore_vert
Inquirer.netEjercito: Probe doctors’ ‘collusion’ with drug firm20 hours agoTina G. SantosBy Tina G. Santosmore_vert
Politiko.com.phJV Ejercito names pharma firm tagged in scam worse than Pharmally scandal2 days agomore_vert
RapplerDoctors in pyramid schemes? DOH reminds medical professionals of ethical code4 days agoKaycee ValmonteBy Kaycee Valmontemore_vert
Inquirer.netDOH to probe docs, pharma firm over marketing scheme2 days agoMarlon Ramos & Dexter CabalzaBy Marlon Ramos & Dexter Cabalzamore_vert
The Economic TimesPharma leads in assigning key managerial roles to women22 hours agoSreeradha BasuBy Sreeradha Basumore_vert
DirectorsTalk InterviewsN4 Pharma to host webinar on collaboration agreement with SRI International12 hours agoAmilia StoneBy Amilia Stonemore_vert
ETHealthWorldShareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer17 hours agomore_vert
ReutersButler Hall Capital urges Vanda to engage in sales discussions7 days agoChristy Santhosh & Krishna Chandra EluriBy Christy Santhosh & Krishna Chandra Elurimore_vert
Investing.comVanda Pharmaceuticals adopts shareholder defense strategy to deter takeover9 days agomore_vert
Business StandardUSFDA pulls up Natco Pharma for several violations at Telangana plant5 days agomore_vert
The Times of IndiaUSFDA: CGMP violations at Natco’s plant7 days agoSwati BharadwajBy Swati Bharadwajmore_vert
NDTV ProfitNatco Pharma Receives Warning Letter From USFDA Over Manufacturing Lapses At Telangana Plant5 days agomore_vert
America First LegalAmerica First Legal Sues HHS Secretary Becerra and National Archives Following Investigation Revealing the Biden Administration Illegally Deletes Former CDC Employees' Email–Illustrating Two-Tiered System of Justice9 days agomore_vert
Fox NewsBiden admin hit with lawsuit for deleting emails in case that could have consequences for Trump9 days agoThomas CatenacciBy Thomas Catenaccimore_vert
Washington ExaminerBiden administration sued over email deletions in case concerning Trump and his documents trial9 days agoBrady KnoxBy Brady Knoxmore_vert
POLITICO EuropeEU pitches new pharma bonus to cure rare diseases. But will it work?22 days agoCarlo MartuscelliBy Carlo Martuscellimore_vert
The Economic TimesStock market update: Nifty Pharma index advances 0.31% in a weak market13 hours agomore_vert
The Tribune IndiaSolan: No relief provided, pharma units start surrendering licence21 hours agomore_vert
The Financial ExpressUSFDA gives nod to Novartis’ therapy for rare cancer among childrenYesterdaymore_vert
Contemporary PediatricsFirst radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs3 days agoJoshua FitchBy Joshua Fitchmore_vert
Clinical Oncology NewsLutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS2 days agomore_vert
GMA News OnlineLithuania supports PH's move to follow int'l law in South China Sea rowYesterdayGiselle OmbayBy Giselle Ombaymore_vert
manilastandard.netDTI woos Lithuanian companies to invest in ICT, renewable sectorsYesterdaymore_vert
pageone.phLithuanian Investors Urged To Look Into Biz Opportunities In Philippines12 hours agomore_vert
MSNPH, Lithuania to boost economic ties23 hours agoJanine Alexis MiguelBy Janine Alexis Miguelmore_vert